View Future GrowthBespoke Extracts 過去の業績過去 基準チェック /06Bespoke Extractsは17.7%の年平均成長率で業績を伸ばしているが、Pharmaceuticals業界はgrowingで9.4%毎年増加している。売上は成長しており、年平均69.8%の割合である。主要情報17.68%収益成長率54.25%EPS成長率Pharmaceuticals 業界の成長5.95%収益成長率69.76%株主資本利益率n/aネット・マージン-51.34%前回の決算情報30 Sep 2025最近の業績更新更新なしすべての更新を表示Recent updatesお知らせ • May 19Bespoke Extracts, Inc. announced delayed 10-Q filingOn 05/18/2026, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Apr 01Bespoke Extracts, Inc. announced delayed annual 10-K filingOn 03/31/2026, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.お知らせ • Nov 13Bespoke Extracts, Inc. Provides Earnings Guidance for the Fourth Quarter of 2025Bespoke Extracts, Inc. provided earnings guidance for the fourth quarter of 2025. For the period, the company expects Revenue: Projected between $425,000 and $500,000, up 41%–66% year-over-year, driven by continued demand for Fresh Joints and expansion of Doobskis and Dutch Blunts.お知らせ • Aug 28Bespoke Extracts, Inc. Provides Earnings Guidance for the Third Quarter of 2025Bespoke Extracts, Inc. provided earnings guidance for the third quarter of 2025. For the quarter, the company continue to experience sales growth in the new product lines compared the quarter ended September 30, 2024. The Company projects revenue between $425,000 and $450,000 for the quarter ending September 30, 2025, a 53% to 62% increase over $277,471 in the quarter ended September 30, 2024, driven by continued growth of FreshJoints, strong demand for Doobskis and Dutch Blunts, and expanded third-party processing services.お知らせ • Aug 15Bespoke Extracts, Inc. announced delayed 10-Q filingOn 08/14/2025, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • May 16Bespoke Extracts, Inc. announced delayed 10-Q filingOn 05/15/2025, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Apr 01Bespoke Extracts, Inc. announced delayed annual 10-K filingOn 03/31/2025, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.お知らせ • Aug 15Bespoke Extracts, Inc. announced delayed 10-Q filingOn 08/14/2024, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • May 16Bespoke Extracts, Inc. announced delayed 10-Q filingOn 05/14/2024, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Apr 02Bespoke Extracts, Inc. announced delayed annual 10-K filingOn 04/01/2024, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.お知らせ • Nov 15Bespoke Extracts, Inc. announced delayed 10-Q filingOn 11/14/2023, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • May 16Bespoke Extracts, Inc. announced delayed 10-Q filingOn 05/15/2023, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Nov 15Bespoke Extracts, Inc. announced delayed 10-Q filingOn 11/14/2022, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Aug 16Bespoke Extracts, Inc. announced delayed 10-Q filingOn 08/15/2022, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Aug 13Bespoke Extracts, Inc. (OTCPK:BSPK) entered into a definitive agreement to acquire the Assets of Osiris, LLC for $1.58 million.Bespoke Extracts, Inc. (OTCPK:BSPK) entered into a definitive agreement to acquire the Assets of Osiris, LLC for $1.58 million on August 12, 2022. Upon closing, Bespoke will issue 125,000,000 shares of common stock in exchange for the assets of Osiris. 50 percent of these shares will be subject to a six-month lockup period and 50 percent will be subject to a twelve-month lockup period. Bespoke has also agreed to assume up to $125,000 of equipment-based financing following the transaction. Bespoke will also be entering into leases for the Aspen Dispensary, the Glenwood Cultivation Facility and the Glenwood Dispensary. The transaction has been approved by the boards of directors of Bespoke and the members of Osiris and is subject to customary closing conditions, including approvals from Colorado regulatory authorities. The transaction is expected to close in the fourth calendar quarter of 2022.お知らせ • Jan 16Bespoke Extracts, Inc. announced delayed 10-Q filingOn 01/14/2022, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Dec 03Bespoke Extracts, Inc. (OTCPK:BSPK) agreed to acquire Assets of Wonderleaf, LLC from Wonderleaf, LLC for $0.23 million.Bespoke Extracts, Inc. (OTCPK:BSPK) agreed to acquire Assets of Wonderleaf, LLC from Wonderleaf, LLC for $0.23 million on December 2, 2021. Total consideration is to be paid 100% in Bespoke common shares. Bespoke will issue 2.5 million shares as a deposit, and an additional $0.15 of shares at closing according to the daily volume weighted average price of Bespoke common stock for the 30 consecutive trading days prior to closing. The proposed transaction has been unanimously approved by the Bespoke board of directors and is expected to close upon receipt of state and local regulatory approvals and satisfaction of other customary closing conditions.お知らせ • Nov 30Bespoke Extracts, Inc. announced delayed annual 10-K filingOn 11/29/2021, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.お知らせ • Apr 15Bespoke Extracts, Inc. announced delayed 10-Q filingOn 04/14/2021, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Feb 26Bespoke Extracts, Inc. announced that it has received $0.5 million in fundingBespoke Extracts, Inc. (OTCPK:BSPK) announced a securities purchase agreement for a private placement of 10,000,000 shares at an issue price of $0.05 per share for gross proceeds $500,000 on February 25, 2021. The transaction included participation from an accredited investor.お知らせ • Feb 06Bespoke Extracts Welcomes Trend Expert Carly Stojsic as New Director of MarketingBespoke Extracts, Inc. announced the appointment of industry trend expert Carly Stojsic as the company’s new Director of Marketing. Reporting directly to Bespoke CEO Danny Pollack, Stojsic will lead, guide and implement all aspects of the Company’s brand-building and product marketing strategies. For the past 15 years, Stojsic has applied her well-known and seasoned trend expertise to specialty and mass market brands operating within the lifestyle and retail industries. Her acumen in trend forecasting, presentation, unearthing innovative insights, achieving experiential customer engagement, and delivering impactful content marketing and market education, across all categories, has earned her distinction as a much sought after speaker and marketing advisor. For six years, Stojsic served as Market Editor and Senior Trend Specialist for WGSN, the global authority on consumer and design trends. In 2017, she was invited to present her macro consumer trend forecast, titled “The Builds and Collapses of Dimensions on the Trendscape” at MIT in Cambridge, Massachusetts. She has worked with brands that have included Gucci, Miu Miu (Prada Group), HBC, Joe Fresh, P&G, Starbucks and Walmart, among many others. Her consultative work in the cannabis space has included projects with 48North, Dosist, Calyx Wellness and various retailers, as well as brand management with Khalifa Kush Enterprises (Supreme Cannabis Company). Stojsic is perhaps best known in the industry for her ability to capture and captivate audiences with mind-blowing content.お知らせ • Jan 22Bespoke Extracts, Inc. announced that it has received $0.1 million in fundingBespoke Extracts, Inc. (OTCPK:BSPK) announced that it has entered into a securities purchase agreement for a private placement of 2,000,000 common shares at an issue price of $0.05 per share for gross proceeds of $100,000 on January 21, 2021. The transaction included participation from Chief Executive Officer of the company, Danil Pollack. The security issued is subject to hold period.お知らせ • Jan 15Bespoke Extracts, Inc. announced delayed 10-Q filingOn 01/14/2021, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Jan 14Bespoke Extracts, Inc. Announces Its Plan to Reintroduce Umf® (Unique Manuka Factor) 15+ Rated Manuka Honey-Infused Cbd FormulationsBespoke Extracts, Inc. announced its plan to reintroduce UMF® (Unique Manuka Factor) 15+ rated Manuka Honey-infused CBD formulations to be available for purchase on www.bespokeextracts.com beginning in February 2021.お知らせ • Dec 01Bespoke Extracts, Inc. announced delayed annual 10-K filingOn 11/30/2020, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.お知らせ • Nov 25Bespoke Extracts, Inc. Introduces New Premium Product Line-Up of Seven Special CBD FormulationsBespoke Extracts, Inc. introduced a new line of specially-formulated, premium quality, hemp-derived CBD products now available for purchase in its ecommerce store. It introduced a new premium product line-up of seven special CBD formulations created specifically for “Women” and “Sport.” Bespoke’s products have been crafted so an individual can precisely tailor their use of its hemp-derived CBD tinctures and softgels to address their personal wellness objectives.お知らせ • Oct 20Bespoke Extracts, Inc. Appoints Yaniv Rozen as Chief Operating OfficerOn October 13, 2020, Yaniv Rozen was appointed chief operating officer of Bespoke Extracts, Inc. Mr. Rozen has been working as a consultant for start-up companies in the e-commerce industry for the last 5 years. On October 13, 2020, the company entered into a consulting agreement with Mr. Rozen pursuant to which the Company engaged Mr. Rozen to serve as the Company’s chief operating officer on a consultant/independent contractor basis. Mr. Rozen may engage in other business activities while serving as the Company’s chief operating officer.お知らせ • Sep 29Bespoke Extracts, Inc. announced that it has received $0.15 million in fundingBespoke Extracts, Inc. (OTCPK:BSPK) announced a private placement of a non-convertible promissory note in the principal amount of $150,000 on August 31, 2020. The transaction included participation from chief executive officer of the company, Danil Pollack. The note does not bear interest and matures on November 30, 2020.収支内訳Bespoke Extracts の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史OTCPK:BSPK 収益、費用、利益 ( )USD Millions日付収益収益G+A経費研究開発費30 Sep 251-11030 Jun 251-11031 Mar 251-11031 Dec 241-11030 Sep 241-12030 Jun 241-12031 Mar 241-12031 Dec 231-12030 Sep 231-22030 Jun 230-33031 Mar 230-44031 Dec 220-44030 Sep 220-33030 Jun 220-22031 Mar 220-12031 Dec 21001030 Nov 210-11031 Aug 210-11031 May 210-11028 Feb 210-44031 Dec 200-11030 Nov 200-44031 Aug 200-54031 May 200-54029 Feb 200-21030 Nov 190-21031 Aug 1903-3031 May 1901-1028 Feb 190-11030 Nov 180-32031 Aug 180-87031 May 180-76028 Feb 180-99030 Nov 170-88031 Aug 170-77031 May 170-55028 Feb 17000030 Nov 16000031 Aug 16000031 May 160-10029 Feb 160-10030 Nov 150-10031 Aug 150-100質の高い収益: BSPKは現在利益が出ていません。利益率の向上: BSPKは現在利益が出ていません。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: BSPKは利益を出していないが、過去 5 年間で年間17.7%の割合で損失を削減してきた。成長の加速: BSPKの過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。収益対業界: BSPKは利益が出ていないため、過去 1 年間の収益成長をPharmaceuticals業界 ( -4.8% ) と比較することは困難です。株主資本利益率高いROE: BSPKの負債は資産を上回っているため、自己資本利益率を計算することは困難です。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YPharmaceuticals-biotech 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/26 19:17終値2026/05/26 00:00収益2025/09/30年間収益2024/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Bespoke Extracts, Inc. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • May 19Bespoke Extracts, Inc. announced delayed 10-Q filingOn 05/18/2026, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Apr 01Bespoke Extracts, Inc. announced delayed annual 10-K filingOn 03/31/2026, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
お知らせ • Nov 13Bespoke Extracts, Inc. Provides Earnings Guidance for the Fourth Quarter of 2025Bespoke Extracts, Inc. provided earnings guidance for the fourth quarter of 2025. For the period, the company expects Revenue: Projected between $425,000 and $500,000, up 41%–66% year-over-year, driven by continued demand for Fresh Joints and expansion of Doobskis and Dutch Blunts.
お知らせ • Aug 28Bespoke Extracts, Inc. Provides Earnings Guidance for the Third Quarter of 2025Bespoke Extracts, Inc. provided earnings guidance for the third quarter of 2025. For the quarter, the company continue to experience sales growth in the new product lines compared the quarter ended September 30, 2024. The Company projects revenue between $425,000 and $450,000 for the quarter ending September 30, 2025, a 53% to 62% increase over $277,471 in the quarter ended September 30, 2024, driven by continued growth of FreshJoints, strong demand for Doobskis and Dutch Blunts, and expanded third-party processing services.
お知らせ • Aug 15Bespoke Extracts, Inc. announced delayed 10-Q filingOn 08/14/2025, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • May 16Bespoke Extracts, Inc. announced delayed 10-Q filingOn 05/15/2025, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Apr 01Bespoke Extracts, Inc. announced delayed annual 10-K filingOn 03/31/2025, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
お知らせ • Aug 15Bespoke Extracts, Inc. announced delayed 10-Q filingOn 08/14/2024, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • May 16Bespoke Extracts, Inc. announced delayed 10-Q filingOn 05/14/2024, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Apr 02Bespoke Extracts, Inc. announced delayed annual 10-K filingOn 04/01/2024, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
お知らせ • Nov 15Bespoke Extracts, Inc. announced delayed 10-Q filingOn 11/14/2023, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • May 16Bespoke Extracts, Inc. announced delayed 10-Q filingOn 05/15/2023, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Nov 15Bespoke Extracts, Inc. announced delayed 10-Q filingOn 11/14/2022, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Aug 16Bespoke Extracts, Inc. announced delayed 10-Q filingOn 08/15/2022, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Aug 13Bespoke Extracts, Inc. (OTCPK:BSPK) entered into a definitive agreement to acquire the Assets of Osiris, LLC for $1.58 million.Bespoke Extracts, Inc. (OTCPK:BSPK) entered into a definitive agreement to acquire the Assets of Osiris, LLC for $1.58 million on August 12, 2022. Upon closing, Bespoke will issue 125,000,000 shares of common stock in exchange for the assets of Osiris. 50 percent of these shares will be subject to a six-month lockup period and 50 percent will be subject to a twelve-month lockup period. Bespoke has also agreed to assume up to $125,000 of equipment-based financing following the transaction. Bespoke will also be entering into leases for the Aspen Dispensary, the Glenwood Cultivation Facility and the Glenwood Dispensary. The transaction has been approved by the boards of directors of Bespoke and the members of Osiris and is subject to customary closing conditions, including approvals from Colorado regulatory authorities. The transaction is expected to close in the fourth calendar quarter of 2022.
お知らせ • Jan 16Bespoke Extracts, Inc. announced delayed 10-Q filingOn 01/14/2022, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Dec 03Bespoke Extracts, Inc. (OTCPK:BSPK) agreed to acquire Assets of Wonderleaf, LLC from Wonderleaf, LLC for $0.23 million.Bespoke Extracts, Inc. (OTCPK:BSPK) agreed to acquire Assets of Wonderleaf, LLC from Wonderleaf, LLC for $0.23 million on December 2, 2021. Total consideration is to be paid 100% in Bespoke common shares. Bespoke will issue 2.5 million shares as a deposit, and an additional $0.15 of shares at closing according to the daily volume weighted average price of Bespoke common stock for the 30 consecutive trading days prior to closing. The proposed transaction has been unanimously approved by the Bespoke board of directors and is expected to close upon receipt of state and local regulatory approvals and satisfaction of other customary closing conditions.
お知らせ • Nov 30Bespoke Extracts, Inc. announced delayed annual 10-K filingOn 11/29/2021, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
お知らせ • Apr 15Bespoke Extracts, Inc. announced delayed 10-Q filingOn 04/14/2021, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Feb 26Bespoke Extracts, Inc. announced that it has received $0.5 million in fundingBespoke Extracts, Inc. (OTCPK:BSPK) announced a securities purchase agreement for a private placement of 10,000,000 shares at an issue price of $0.05 per share for gross proceeds $500,000 on February 25, 2021. The transaction included participation from an accredited investor.
お知らせ • Feb 06Bespoke Extracts Welcomes Trend Expert Carly Stojsic as New Director of MarketingBespoke Extracts, Inc. announced the appointment of industry trend expert Carly Stojsic as the company’s new Director of Marketing. Reporting directly to Bespoke CEO Danny Pollack, Stojsic will lead, guide and implement all aspects of the Company’s brand-building and product marketing strategies. For the past 15 years, Stojsic has applied her well-known and seasoned trend expertise to specialty and mass market brands operating within the lifestyle and retail industries. Her acumen in trend forecasting, presentation, unearthing innovative insights, achieving experiential customer engagement, and delivering impactful content marketing and market education, across all categories, has earned her distinction as a much sought after speaker and marketing advisor. For six years, Stojsic served as Market Editor and Senior Trend Specialist for WGSN, the global authority on consumer and design trends. In 2017, she was invited to present her macro consumer trend forecast, titled “The Builds and Collapses of Dimensions on the Trendscape” at MIT in Cambridge, Massachusetts. She has worked with brands that have included Gucci, Miu Miu (Prada Group), HBC, Joe Fresh, P&G, Starbucks and Walmart, among many others. Her consultative work in the cannabis space has included projects with 48North, Dosist, Calyx Wellness and various retailers, as well as brand management with Khalifa Kush Enterprises (Supreme Cannabis Company). Stojsic is perhaps best known in the industry for her ability to capture and captivate audiences with mind-blowing content.
お知らせ • Jan 22Bespoke Extracts, Inc. announced that it has received $0.1 million in fundingBespoke Extracts, Inc. (OTCPK:BSPK) announced that it has entered into a securities purchase agreement for a private placement of 2,000,000 common shares at an issue price of $0.05 per share for gross proceeds of $100,000 on January 21, 2021. The transaction included participation from Chief Executive Officer of the company, Danil Pollack. The security issued is subject to hold period.
お知らせ • Jan 15Bespoke Extracts, Inc. announced delayed 10-Q filingOn 01/14/2021, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Jan 14Bespoke Extracts, Inc. Announces Its Plan to Reintroduce Umf® (Unique Manuka Factor) 15+ Rated Manuka Honey-Infused Cbd FormulationsBespoke Extracts, Inc. announced its plan to reintroduce UMF® (Unique Manuka Factor) 15+ rated Manuka Honey-infused CBD formulations to be available for purchase on www.bespokeextracts.com beginning in February 2021.
お知らせ • Dec 01Bespoke Extracts, Inc. announced delayed annual 10-K filingOn 11/30/2020, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
お知らせ • Nov 25Bespoke Extracts, Inc. Introduces New Premium Product Line-Up of Seven Special CBD FormulationsBespoke Extracts, Inc. introduced a new line of specially-formulated, premium quality, hemp-derived CBD products now available for purchase in its ecommerce store. It introduced a new premium product line-up of seven special CBD formulations created specifically for “Women” and “Sport.” Bespoke’s products have been crafted so an individual can precisely tailor their use of its hemp-derived CBD tinctures and softgels to address their personal wellness objectives.
お知らせ • Oct 20Bespoke Extracts, Inc. Appoints Yaniv Rozen as Chief Operating OfficerOn October 13, 2020, Yaniv Rozen was appointed chief operating officer of Bespoke Extracts, Inc. Mr. Rozen has been working as a consultant for start-up companies in the e-commerce industry for the last 5 years. On October 13, 2020, the company entered into a consulting agreement with Mr. Rozen pursuant to which the Company engaged Mr. Rozen to serve as the Company’s chief operating officer on a consultant/independent contractor basis. Mr. Rozen may engage in other business activities while serving as the Company’s chief operating officer.
お知らせ • Sep 29Bespoke Extracts, Inc. announced that it has received $0.15 million in fundingBespoke Extracts, Inc. (OTCPK:BSPK) announced a private placement of a non-convertible promissory note in the principal amount of $150,000 on August 31, 2020. The transaction included participation from chief executive officer of the company, Danil Pollack. The note does not bear interest and matures on November 30, 2020.